These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34117734)
1. DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-inflammatory agents for COVID-19. Wang X; Xin B; Tan W; Xu Z; Li K; Li F; Zhong W; Peng S Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34117734 [TBL] [Abstract][Full Text] [Related]
2. LUNAR :Drug Screening for Novel Coronavirus Based on Representation Learning Graph Convolutional Network. Zhou D; Peng S; Wei DQ; Zhong W; Dou Y; Xie X IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1290-1298. PubMed ID: 34081583 [TBL] [Abstract][Full Text] [Related]
3. deepDR: a network-based deep learning approach to in silico drug repositioning. Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390 [TBL] [Abstract][Full Text] [Related]
4. BioERP: biomedical heterogeneous network-based self-supervised representation learning approach for entity relationship predictions. Wang X; Yang Y; Li K; Li W; Li F; Peng S Bioinformatics; 2021 Dec; 37(24):4793-4800. PubMed ID: 34329382 [TBL] [Abstract][Full Text] [Related]
5. DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach. Lv H; Dao FY; Zulfiqar H; Lin H Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34184738 [TBL] [Abstract][Full Text] [Related]
6. DLDTI: a learning-based framework for drug-target interaction identification using neural networks and network representation. Zhao Y; Zheng K; Guan B; Guo M; Song L; Gao J; Qu H; Wang Y; Shi D; Zhang Y J Transl Med; 2020 Nov; 18(1):434. PubMed ID: 33187537 [TBL] [Abstract][Full Text] [Related]
7. Drug repurposing for COVID-19 via knowledge graph completion. Zhang R; Hristovski D; Schutte D; Kastrin A; Fiszman M; Kilicoglu H J Biomed Inform; 2021 Mar; 115():103696. PubMed ID: 33571675 [TBL] [Abstract][Full Text] [Related]
8. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2. Wang S; Sun Q; Xu Y; Pei J; Lai L Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143 [TBL] [Abstract][Full Text] [Related]
10. Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence. Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y Sci Rep; 2021 Nov; 11(1):23179. PubMed ID: 34848761 [TBL] [Abstract][Full Text] [Related]
11. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy. Wang M; Fu D; Yao L; Li J Comb Chem High Throughput Screen; 2021; 24(2):294-305. PubMed ID: 32767929 [TBL] [Abstract][Full Text] [Related]
12. DeepDILI: Deep Learning-Powered Drug-Induced Liver Injury Prediction Using Model-Level Representation. Li T; Tong W; Roberts R; Liu Z; Thakkar S Chem Res Toxicol; 2021 Feb; 34(2):550-565. PubMed ID: 33356151 [TBL] [Abstract][Full Text] [Related]
13. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2. Su X; Hu L; You Z; Hu P; Wang L; Zhao B Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582 [TBL] [Abstract][Full Text] [Related]
14. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification. Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419 [TBL] [Abstract][Full Text] [Related]
15. Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Rogosnitzky M; Okediji P; Koman I Pharmacol Rep; 2020 Dec; 72(6):1509-1516. PubMed ID: 32700247 [TBL] [Abstract][Full Text] [Related]
16. ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides. Timmons PB; Hewage CM Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34297817 [TBL] [Abstract][Full Text] [Related]
17. Learning global dependencies and multi-semantics within heterogeneous graph for predicting disease-related lncRNAs. Xuan P; Wang S; Cui H; Zhao Y; Zhang T; Wu P Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 36088549 [TBL] [Abstract][Full Text] [Related]
18. Recent omics-based computational methods for COVID-19 drug discovery and repurposing. Tayara H; Abdelbaky I; To Chong K Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353 [TBL] [Abstract][Full Text] [Related]
19. Multiphysical graph neural network (MP-GNN) for COVID-19 drug design. Li XS; Liu X; Lu L; Hua XS; Chi Y; Xia K Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35696650 [TBL] [Abstract][Full Text] [Related]